179 related articles for article (PubMed ID: 1340156)
1. Modulation of c-myc transcription by triple helix formation.
Postel EH
Ann N Y Acad Sci; 1992 Oct; 660():57-63. PubMed ID: 1340156
[TBL] [Abstract][Full Text] [Related]
2. Evidence that a triplex-forming oligodeoxyribonucleotide binds to the c-myc promoter in HeLa cells, thereby reducing c-myc mRNA levels.
Postel EH; Flint SJ; Kessler DJ; Hogan ME
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8227-31. PubMed ID: 1896473
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of nuclear protein binding to two sites in the murine c-myc promoter by intermolecular triplex formation.
Reddoch JF; Miller DM
Biochemistry; 1995 Jun; 34(23):7659-67. PubMed ID: 7779812
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of in vitro transcription by a triplex-forming oligonucleotide targeted to human c-myc P2 promoter.
Kim HG; Miller DM
Biochemistry; 1995 Jun; 34(25):8165-71. PubMed ID: 7794930
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of transcription of the human c-myc protooncogene by intermolecular triplex.
Kim HG; Reddoch JF; Mayfield C; Ebbinghaus S; Vigneswaran N; Thomas S; Jones DE; Miller DM
Biochemistry; 1998 Feb; 37(8):2299-304. PubMed ID: 9485376
[TBL] [Abstract][Full Text] [Related]
6. DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.
Carbone GM; McGuffie E; Napoli S; Flanagan CE; Dembech C; Negri U; Arcamone F; Capobianco ML; Catapano CV
Nucleic Acids Res; 2004; 32(8):2396-410. PubMed ID: 15121897
[TBL] [Abstract][Full Text] [Related]
7. Triplex formation inhibits HER-2/neu transcription in vitro.
Ebbinghaus SW; Gee JE; Rodu B; Mayfield CA; Sanders G; Miller DM
J Clin Invest; 1993 Nov; 92(5):2433-9. PubMed ID: 7901237
[TBL] [Abstract][Full Text] [Related]
8. PuF/NM23-H2/NDPK-B transactivates a human c-myc promoter-CAT gene via a functional nuclease hypersensitive element.
Berberich SJ; Postel EH
Oncogene; 1995 Jun; 10(12):2343-7. PubMed ID: 7784082
[TBL] [Abstract][Full Text] [Related]
9. A nuclease-hypersensitive element of the human c-myc promoter interacts with a transcription initiation factor.
Postel EH; Mango SE; Flint SJ
Mol Cell Biol; 1989 Nov; 9(11):5123-33. PubMed ID: 2601711
[TBL] [Abstract][Full Text] [Related]
10. A novel triplex-forming oligonucleotide targeted to human cyclin D1 (bcl-1, proto-oncogene) promoter inhibits transcription in HeLa cells.
Kim HG; Miller DM
Biochemistry; 1998 Feb; 37(8):2666-72. PubMed ID: 9485417
[TBL] [Abstract][Full Text] [Related]
11. c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro.
Lavrovsky Y; Stoltz RA; Vlassov VV; Abraham NG
Eur J Biochem; 1996 Jun; 238(2):582-90. PubMed ID: 8681975
[TBL] [Abstract][Full Text] [Related]
12. Triplex forming ability of a c-myc promoter element predicts promoter strength.
Firulli AB; Maibenco DC; Kinniburgh AJ
Arch Biochem Biophys; 1994 Apr; 310(1):236-42. PubMed ID: 8161210
[TBL] [Abstract][Full Text] [Related]
13. Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters.
DesJardins E; Hay N
Mol Cell Biol; 1993 Sep; 13(9):5710-24. PubMed ID: 8355712
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gene expression by triple helix-directed DNA cross-linking at specific sites.
Grigoriev M; Praseuth D; Guieysse AL; Robin P; Thuong NT; Hélène C; Harel-Bellan A
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3501-5. PubMed ID: 8475098
[TBL] [Abstract][Full Text] [Related]
15. Oligonucleotide inhibition of IL2R alpha mRNA transcription by promoter region collinear triplex formation in lymphocytes.
Orson FM; Thomas DW; McShan WM; Kessler DJ; Hogan ME
Nucleic Acids Res; 1991 Jun; 19(12):3435-41. PubMed ID: 2062658
[TBL] [Abstract][Full Text] [Related]
16. Mithramycin blocks transcriptional initiation of the c-myc P1 and P2 promoters.
Snyder RC; Ray R; Blume S; Miller DM
Biochemistry; 1991 Apr; 30(17):4290-7. PubMed ID: 1827033
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional inhibition of the bacteriophage T7 early promoter region by oligonucleotide triple helix formation.
Ross C; Samuel M; Broitman SL
Biochem Biophys Res Commun; 1992 Dec; 189(3):1674-80. PubMed ID: 1482373
[TBL] [Abstract][Full Text] [Related]
18. Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.
McGuffie EM; Catapano CV
Nucleic Acids Res; 2002 Jun; 30(12):2701-9. PubMed ID: 12060688
[TBL] [Abstract][Full Text] [Related]
19. Site-specific oligonucleotide binding represses transcription of the human c-myc gene in vitro.
Cooney M; Czernuszewicz G; Postel EH; Flint SJ; Hogan ME
Science; 1988 Jul; 241(4864):456-9. PubMed ID: 3293213
[TBL] [Abstract][Full Text] [Related]
20. A triple helix-forming oligonucleotide-intercalator conjugate acts as a transcriptional repressor via inhibition of NF kappa B binding to interleukin-2 receptor alpha-regulatory sequence.
Grigoriev M; Praseuth D; Robin P; Hemar A; Saison-Behmoaras T; Dautry-Varsat A; Thuong NT; Hélène C; Harel-Bellan A
J Biol Chem; 1992 Feb; 267(5):3389-95. PubMed ID: 1737792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
